Developer docs
API playgroundTry for free, no card

Search company profiles

Accredo Health

Full company profile

uuid000yzft

Namestring
Accredo Health
Legal namestring
Accredo Health Group, Inc.
Websiteurl
accredo.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Accredo Health Group, Inc. is a US specialty pharmacy headquartered in Memphis, TN, operating as a wholly-owned subsidiary of Evernorth Health Services, the health services division of The Cigna Group (NYSE: CI). Founded in 1996 (with specialty pharmacy accreditations dating to 2003) and 1,001–5,000 employees, Accredo dispenses high-cost specialty medications and provides condition-specific clinical support for patients with complex and chronic conditions, including cancer, hepatitis C, HIV, bleeding disorders, multiple sclerosis, immune disorders, and 23 rare diseases. Service delivery is organized around 15 Therapeutic Resource Centers (TRCs) staffed by 500+ specialty-trained pharmacists and 600+ infusion nurses, supported by 9 URAC-accredited strategic distribution locations across the US plus mail-order and in-home infusion delivery.

The technology stack centers on AI-enabled prior authorization (Smart Coverage Review), the iAssist clinical tool, the MyAccredoPatients portal (adopted by 70% of specialty providers and 65% of patients), the Accredo mobile app, and Surescripts/EHR integration for electronic prescribing. In July 2026, Evernorth launched Pharmacy Forward, a $100M AI-powered specialty pharmacy initiative rolling out first through Accredo with projected $400M value generation by 2028 and targets of 50% documentation-time reduction and 2x faster medication delivery.

Accredo generates revenue primarily through negotiated pharmacy dispensing rates with payers and health plans (transaction-fee model), managed-services compensation for clinical/patient support (including manufacturer-funded hub programs), and specialty distribution margins between acquisition cost and dispensed product pricing. GTM is sales-led via healthcare provider referrals and prescriber relationships, augmented by self-serve patient portal and mobile app enrollment, and underwritten by enterprise distribution through Cigna health plan membership and Express Scripts PBM formulary access.

Short descriptiontext

Accredo Health is a US specialty pharmacy subsidiary of Evernorth/Cigna that dispenses specialty medications and delivers condition-specific clinical support for patients with complex, chronic, and rare diseases across 15 Therapeutic Resource Centers, an in-home infusion nursing network, and AI-enabled prior authorization tooling.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersMemphis, United States
HQ citystring
Memphis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices13 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmacy services, complex medication management, home infusion nursing, prior authorization automation, condition-specific clinical care
Industry3 codes
1Specialty Pharmacy & Complex Therapy Management Platforms
CodeHLACAKAGPrimaryYes
2Hospital & Health-System Pharmacies (Inpatient/Outpatient)
CodeHLAFALABPrimaryNo
3Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP)
CodeHLACAKAOPrimaryNo
NAICS code3 codes
  • Pharmacies and Drug Retailers45611
  • Pharmacies and Drug Retailers456110
  • Ambulatory Health Care Services621
SIC code3 codes
  • Retail-Drug Stores And Proprietary Stores5912
  • Services-Health Services8000
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Specialty Pharmacy Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Pharmacy Dispensing Services
TypeTransaction Fee
Description

Accredo dispenses specialty medications pursuant to prescriptions. Revenue generated from negotiated rates with clients (payers, health plans) for medication dispensing, including applicable dispensing fees. Margins realized between net acquisition cost and amounts paid by clients for dispensed products.

accredo.com
2Clinical and Patient Support Services
TypeManaged Services
Description

Ongoing clinical support including patient education, therapy adherence counseling, physician consultations, authorization maintenance, and care coordination. May receive compensation from manufacturers related to provision of certain programs or pharmacy services.

accredo.com
3AI-Enabled Process Automation
TypeManaged Services
Description

Technology-enabled prior authorization and clinical documentation services. Cigna pilot on rheumatoid arthritis patients achieved 58% auto-approval rates and cut overall workload to 40%. Express Scripts auto-decisioning approximately 10% of cases via SCR logic.

evernorth.com
4Specialty Distribution
TypeHardware Sales
Description

Purchase of prescription drug inventories from manufacturers or wholesalers, dispensing to patients or distribution to physician offices. Realization of overall positive margins through net acquisition cost versus dispensed product pricing.

accredo.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Specialty pharmacy services covered through insurance and pharmacy benefit management
ModelOtherBilling cadencePay-as-you-go
Notes

Accredo services are not priced directly to patients; services are billed to health plans, payers, and clients. Medication costs determined through insurance eligibility verification and coverage checks performed by Accredo.

accredo.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1MyAccredoPatients (MAP)
Description

Digital patient portal and communication platform enabling patients to manage prescriptions and receive updates

accredo.com
+5 more records
Core offering1 text field

Accredo Health operates as a specialty pharmacy that dispenses specialty medications and provides condition-specific clinical support to patients with complex and chronic conditions, including cancer, hepatitis C, HIV, bleeding disorders, multiple sclerosis, immune disorders, and rare diseases. Services are delivered through 15 Therapeutic Resource Centers staffed by 500+ specialty-trained pharmacists and 600+ infusion nurses, supported by digital tools (mobile app, MyAccredoPatients portal) and AI-enabled prior authorization (Smart Coverage Review, Pharmacy Forward AI).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Reduces clinician documentation time by up to 50%
+6 more records
Product overview1 text field

Accredo Health operates as a specialty pharmacy focused on managing complex and chronic conditions through a platform-plus-services model. The core offering is the Accredo Specialty Pharmacy platform, which delivers medications and clinical support through 15 condition-specific Therapeutic Resource Centers (TRCs) staffed by 500+ specialty-trained pharmacists and 600+ infusion nurses. This platform is enhanced by digital tools including the Accredo Mobile App, MyAccredoPatients (MAP) patient portal, and the AI-enabled Smart Coverage Review (SCR) for prior authorization. Financial support services include copay assistance programs. The recent Pharmacy Forward AI program represents a significant technology advancement, applying AI and automation to streamline prior authorization, reduce documentation burden, and improve medication delivery times across the specialty pharmacy network.

Product and service5 records
1Accredo Specialty Pharmacy
CategorySpecialty Pharmacy Services
Description

Specialty pharmacy dispensing and clinical management services for patients with complex and chronic conditions including cancer, hepatitis C, HIV, bleeding disorders, multiple sclerosis, immune disorders, and rare diseases. Delivered via 15 condition-specific Therapeutic Resource Centers, mail-order delivery, in-home infusion, and 24/7 pharmacist support; revenue generated through negotiated rates with health plans, payers, and clients.

2Therapeutic Resource Centers (TRCs)
CategorySpecialty Pharmacy Services
Description

15 condition-specific clinical centers providing specialized expertise and coordinated care for particular therapeutic areas, supported by 500 specialty-trained pharmacists and 600+ specialty-trained infusion nurses providing in-home care.

3Accredo Mobile App
CategorySpecialty Pharmacy Services
Description

Mobile application available on iOS and Android for managing specialty medications on the go, including prescription refills, order tracking, medication history, dose reminders, balance payments, and symptom tracking.

4Pharmacy Forward
CategorySpecialty Pharmacy Services
Description

AI-powered specialty pharmacy program developed by Evernorth and launching first through Accredo. Uses AI to integrate clinical data, reduce clinician documentation time by up to 50%, halve patient wait times for medication, and cut prior authorization processing time by 50%. Backed by a $100 million investment through 2028, expected to generate $400 million in projected value by end of 2028.

5Copay Assistance Program
CategorySpecialty Pharmacy Services
Description

Financial assistance program helping patients find and apply for copay assistance programs tailored to their medications through an easy-to-search online tool.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Evernorth Health Services is the health services unit of Cigna Group that created and launched the Pharmacy Forward AI-powered specialty pharmacy program backed by $100 million investment through 2028, launching first through Accredo. Accredo operates as a key subsidiary and strategic distribution channel within the Evernorth portfolio of pharmacy, care and benefits solutions.

Strategic tierCoreTypeTechnology or Integration
Description

Express Scripts is Cigna's pharmacy benefit management subsidiary. Accredo integrates with Express Scripts for prior authorization processing via Smart Coverage Review (SCR) logic, which answered 3 million questions across 2.4 million cases in 2022. Express Scripts auto-decisioned approximately 10% of cases through SCR technology.

Strategic tierCoreTypeTechnology or Integration
Description

Surescripts Specialty Patient Enrollment service integrates electronic enrollment forms with e-prescribing systems, cost information and electronic prior authorizations. Accredo participates in this network representing nearly 53% of the specialty pharmacy market, having processed over 15,000 specialty patient enrollment forms electronically.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Cigna Healthcare is the health insurance division of The Cigna Group. Accredo serves as the specialty pharmacy for Cigna health plans through Evernorth integration, providing coordinated specialty pharmacy services to Cigna members managing complex and chronic conditions.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Accredo purchases prescription drug inventories directly from manufacturers or wholesalers for dispensing to patients or distribution to physician offices. Manufacturers provide purchasing discounts in the form of up-front and retrospective discounts, and may require HIPAA-compliant reporting on service levels and dispensing data.

Strategic tierMinorTypeGTM or Marketing Partner
Description

InsideRX is a site and partner listed on the Accredo website, representing a pharmacy savings program that works alongside Accredo services.

Strategic tierMinorTypeGTM or Marketing Partner
Description

MD LIVE by Evernorth is a telehealth partner listed on the Accredo website, providing virtual care services integrated with Evernorth Health Services ecosystem.

8Major EHR Vendors (Cerner, eMDs, Quanum)
Strategic tierCoreTypeTechnology or Integration
Description

Major EHR vendors including Cerner, eMDs and Quanum have contracted for Surescripts Specialty Patient Enrollment service, representing nearly 53% of the specialty pharmacy market. Accredo benefits from this connectivity for electronic prescribing workflows.

evernorth.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty pharmacy offering home infusion, limited distribution therapies, and condition-specific clinical management; competes with Accredo in complex/rare therapy management.

TypeDirect peer
Description

Specialty pharmacy arm of CVS Health/Caremark, offering mail-order specialty medications, clinical support, and condition-specific care — directly comparable in services, distribution model, and PBM-affiliated scale.

TypeDirect peer
Description

Specialty pharmacy within UnitedHealth Group/OptumRx; competes head-to-head in dispensing specialty therapies, prior authorization, and condition management for complex and chronic patients.

TypeBroad incumbent
Description

Cigna's PBM and Accredo's sister entity; provides PBM infrastructure, prior authorization (Smart Coverage Review), and formulary management that directly drives Accredo's specialty volume.

TypeDirect peer
Description

Independent specialty pharmacy specializing in rare disease, oncology, and limited distribution drugs — comparable in condition-specific expertise and patient services to Accredo's TRCs.

TypeDirect peer
Description

Specialty pharmacy services from Walgreens, including limited distribution drugs and condition-specific care programs — directly overlapping service mix with Accredo.

TypeBroad incumbent
Description

Parent organization of Accredo; broader health services platform spanning pharmacy, care, and benefit solutions that uses Accredo as a core specialty distribution and clinical channel.

TypeDirect peer
Description

Specialty pharmacy within Humana serving complex-condition members through integrated PBM and payer relationships; mirrors Accredo's PBM-affiliated specialty model.

TypeEmerging player
Description

Historically a leading independent specialty pharmacy focused on limited distribution and rare therapies; now integrated into Optum but a useful comparable for Accredo's specialty distribution and rare-disease capabilities.

TypeOthers
Description

E-prescribing and health information network integrated with Accredo for specialty patient enrollment and electronic prior authorizations — key ecosystem enabler rather than a direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Accredo Health

Specialty Pharmacy Servicesaccredo.com

Accredo Health is a US specialty pharmacy subsidiary of Evernorth/Cigna that dispenses specialty medications and delivers condition-specific clinical support for patients with complex, chronic, and rare diseases across 15 Therapeutic Resource Centers, an in-home infusion nursing network, and AI-enabled prior authorization tooling.

What Accredo Health does

Accredo Health Group, Inc. is a US specialty pharmacy headquartered in Memphis, TN, operating as a wholly-owned subsidiary of Evernorth Health Services, the health services division of The Cigna Group (NYSE: CI). Founded in 1996 (with specialty pharmacy accreditations dating to 2003) and 1,001–5,000 employees, Accredo dispenses high-cost specialty medications and provides condition-specific clinical support for patients with complex and chronic conditions, including cancer, hepatitis C, HIV, bleeding disorders, multiple sclerosis, immune disorders, and 23 rare diseases. Service delivery is organized around 15 Therapeutic Resource Centers (TRCs) staffed by 500+ specialty-trained pharmacists and 600+ infusion nurses, supported by 9 URAC-accredited strategic distribution locations across the US plus mail-order and in-home infusion delivery.

The technology stack centers on AI-enabled prior authorization (Smart Coverage Review), the iAssist clinical tool, the MyAccredoPatients portal (adopted by 70% of specialty providers and 65% of patients), the Accredo mobile app, and Surescripts/EHR integration for electronic prescribing. In July 2026, Evernorth launched Pharmacy Forward, a $100M AI-powered specialty pharmacy initiative rolling out first through Accredo with projected $400M value generation by 2028 and targets of 50% documentation-time reduction and 2x faster medication delivery.

Accredo generates revenue primarily through negotiated pharmacy dispensing rates with payers and health plans (transaction-fee model), managed-services compensation for clinical/patient support (including manufacturer-funded hub programs), and specialty distribution margins between acquisition cost and dispensed product pricing. GTM is sales-led via healthcare provider referrals and prescriber relationships, augmented by self-serve patient portal and mobile app enrollment, and underwritten by enterprise distribution through Cigna health plan membership and Express Scripts PBM formulary access.

Accredo Health firmographics

Firmographics
Name
Accredo Health
Legal name
Accredo Health Group, Inc.
Website
https://accredo.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Accredo Health is a US specialty pharmacy subsidiary of Evernorth/Cigna that dispenses specialty medications and delivers condition-specific clinical support for patients with complex, chronic, and rare diseases across 15 Therapeutic Resource Centers, an in-home infusion nursing network, and AI-enabled prior authorization tooling.
Ownership category
akta.pro rank

Accredo Health industry classification

Industry
Product category
Specialty Pharmacy Services
NAICS
Pharmacies and Drug Retailers (45611), Pharmacies and Drug Retailers (456110), Ambulatory Health Care Services (621)
SIC
Retail-Drug Stores And Proprietary Stores (5912), Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
akta.pro secondary industries
Hospital & Health-System Pharmacies (Inpatient/Outpatient) (HLAFALAB), Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP) (HLACAKAO)

Keywords

  • Specialty pharmacy services
  • Complex medication management
  • Home infusion nursing
  • Prior authorization automation
  • Condition-specific clinical care

Where Accredo Health is headquartered

Location

Headquarters

HQ city
Memphis
HQ country
United States
HQ region
North America

Offices13 records

Markets served

Accredo Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmacy Dispensing Services: Accredo dispenses specialty medications pursuant to prescriptions. Revenue generated from negotiated rates with clients (payers, health plans) for medication dispensing, including applicable dispensing fees. Margins realized between net acquisition cost and amounts paid by clients for dispensed products.
  2. Clinical and Patient Support Services: Ongoing clinical support including patient education, therapy adherence counseling, physician consultations, authorization maintenance, and care coordination. May receive compensation from manufacturers related to provision of certain programs or pharmacy services.
  3. AI-Enabled Process Automation: Technology-enabled prior authorization and clinical documentation services. Cigna pilot on rheumatoid arthritis patients achieved 58% auto-approval rates and cut overall workload to 40%. Express Scripts auto-decisioning approximately 10% of cases via SCR logic.
  4. Specialty Distribution: Purchase of prescription drug inventories from manufacturers or wholesalers, dispensing to patients or distribution to physician offices. Realization of overall positive margins through net acquisition cost versus dispensed product pricing.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goSpecialty pharmacy services covered through insurance and pharmacy benefit management

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Accredo Health product offering

Product offering

Core offering

Accredo Health operates as a specialty pharmacy that dispenses specialty medications and provides condition-specific clinical support to patients with complex and chronic conditions, including cancer, hepatitis C, HIV, bleeding disorders, multiple sclerosis, immune disorders, and rare diseases. Services are delivered through 15 Therapeutic Resource Centers staffed by 500+ specialty-trained pharmacists and 600+ infusion nurses, supported by digital tools (mobile app, MyAccredoPatients portal) and AI-enabled prior authorization (Smart Coverage Review, Pharmacy Forward AI).

Product overview

Accredo Health operates as a specialty pharmacy focused on managing complex and chronic conditions through a platform-plus-services model. The core offering is the Accredo Specialty Pharmacy platform, which delivers medications and clinical support through 15 condition-specific Therapeutic Resource Centers (TRCs) staffed by 500+ specialty-trained pharmacists and 600+ infusion nurses. This platform is enhanced by digital tools including the Accredo Mobile App, MyAccredoPatients (MAP) patient portal, and the AI-enabled Smart Coverage Review (SCR) for prior authorization. Financial support services include copay assistance programs. The recent Pharmacy Forward AI program represents a significant technology advancement, applying AI and automation to streamline prior authorization, reduce documentation burden, and improve medication delivery times across the specialty pharmacy network.

Differentiator

Problem solved

Functional benefit

Brands

  • MyAccredoPatients (MAP): Digital patient portal and communication platform enabling patients to manage prescriptions and receive updates
  • iAssist
  • Smart Coverage Review (SCR)
  • Therapease Cuisine
  • GeneAxS
  • OneAdherence

Products and services

  • Accredo Specialty Pharmacy Specialty pharmacy dispensing and clinical management services for patients with complex and chronic conditions including cancer, hepatitis C, HIV, bleeding disorders, multiple sclerosis, immune disorders, and rare diseases. Delivered via 15 condition-specific Therapeutic Resource Centers, mail-order delivery, in-home infusion, and 24/7 pharmacist support; revenue generated through negotiated rates with health plans, payers, and clients.
  • Therapeutic Resource Centers (TRCs) 15 condition-specific clinical centers providing specialized expertise and coordinated care for particular therapeutic areas, supported by 500 specialty-trained pharmacists and 600+ specialty-trained infusion nurses providing in-home care.
  • Accredo Mobile App Mobile application available on iOS and Android for managing specialty medications on the go, including prescription refills, order tracking, medication history, dose reminders, balance payments, and symptom tracking.
  • Pharmacy Forward AI-powered specialty pharmacy program developed by Evernorth and launching first through Accredo. Uses AI to integrate clinical data, reduce clinician documentation time by up to 50%, halve patient wait times for medication, and cut prior authorization processing time by 50%. Backed by a $100 million investment through 2028, expected to generate $400 million in projected value by end of 2028.
  • Copay Assistance Program Financial assistance program helping patients find and apply for copay assistance programs tailored to their medications through an easy-to-search online tool.

Quantifiable outcome

  • Reduces clinician documentation time by up to 50%
  • +6 more outcomes

Companies that use Accredo Health

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Accredo Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature7 records

Accredo Health partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

  • Evernorth Health ServicesflagshipStrategic or Co-development PartnerEvernorth Health Services is the health services unit of Cigna Group that created and launched the Pharmacy Forward AI-powered specialty pharmacy program backed by $100 million investment through 2028, launching first through Accredo. Accredo operates as a key subsidiary and strategic distribution channel within the Evernorth portfolio of pharmacy, care and benefits solutions.
  • Express ScriptscoreTechnology or IntegrationExpress Scripts is Cigna's pharmacy benefit management subsidiary. Accredo integrates with Express Scripts for prior authorization processing via Smart Coverage Review (SCR) logic, which answered 3 million questions across 2.4 million cases in 2022. Express Scripts auto-decisioned approximately 10% of cases through SCR technology.
  • SurescriptscoreTechnology or IntegrationSurescripts Specialty Patient Enrollment service integrates electronic enrollment forms with e-prescribing systems, cost information and electronic prior authorizations. Accredo participates in this network representing nearly 53% of the specialty pharmacy market, having processed over 15,000 specialty patient enrollment forms electronically.
  • Cigna HealthcareflagshipStrategic or Co-development PartnerCigna Healthcare is the health insurance division of The Cigna Group. Accredo serves as the specialty pharmacy for Cigna health plans through Evernorth integration, providing coordinated specialty pharmacy services to Cigna members managing complex and chronic conditions.
  • Pharmaceutical ManufacturerscoreChannel Partner/ Reseller/ DistributorAccredo purchases prescription drug inventories directly from manufacturers or wholesalers for dispensing to patients or distribution to physician offices. Manufacturers provide purchasing discounts in the form of up-front and retrospective discounts, and may require HIPAA-compliant reporting on service levels and dispensing data.
  • InsideRXminorGTM or Marketing PartnerInsideRX is a site and partner listed on the Accredo website, representing a pharmacy savings program that works alongside Accredo services.
  • MD LIVE by EvernorthminorGTM or Marketing PartnerMD LIVE by Evernorth is a telehealth partner listed on the Accredo website, providing virtual care services integrated with Evernorth Health Services ecosystem.
  • Major EHR Vendors (Cerner, eMDs, Quanum)coreTechnology or IntegrationMajor EHR vendors including Cerner, eMDs and Quanum have contracted for Surescripts Specialty Patient Enrollment service, representing nearly 53% of the specialty pharmacy market. Accredo benefits from this connectivity for electronic prescribing workflows.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Accredo Health competitors and assessment

Company assessment

Direct peers

  • BioMatrix Specialty Pharmacy: Specialty pharmacy offering home infusion, limited distribution therapies, and condition-specific clinical management; competes with Accredo in complex/rare therapy management.
  • CVS Specialty (CVS Health): Specialty pharmacy arm of CVS Health/Caremark, offering mail-order specialty medications, clinical support, and condition-specific care — directly comparable in services, distribution model, and PBM-affiliated scale.
  • Optum Specialty Pharmacy (OptumRx): Specialty pharmacy within UnitedHealth Group/OptumRx; competes head-to-head in dispensing specialty therapies, prior authorization, and condition management for complex and chronic patients.
  • PANTHERx Specialty Pharmacy: Independent specialty pharmacy specializing in rare disease, oncology, and limited distribution drugs — comparable in condition-specific expertise and patient services to Accredo's TRCs.
  • Walgreens Specialty Pharmacy: Specialty pharmacy services from Walgreens, including limited distribution drugs and condition-specific care programs — directly overlapping service mix with Accredo.
  • Humana Specialty Pharmacy: Specialty pharmacy within Humana serving complex-condition members through integrated PBM and payer relationships; mirrors Accredo's PBM-affiliated specialty model.

Broad incumbents

  • Express Scripts (Pharmacy Benefit Services): Cigna's PBM and Accredo's sister entity; provides PBM infrastructure, prior authorization (Smart Coverage Review), and formulary management that directly drives Accredo's specialty volume.
  • Cigna / Evernorth Health Services: Parent organization of Accredo; broader health services platform spanning pharmacy, care, and benefit solutions that uses Accredo as a core specialty distribution and clinical channel.

Emerging players

  • Diplomat Pharmacy (now part of Optum): Historically a leading independent specialty pharmacy focused on limited distribution and rare therapies; now integrated into Optum but a useful comparable for Accredo's specialty distribution and rare-disease capabilities.

Others

  • Surescripts: E-prescribing and health information network integrated with Accredo for specialty patient enrollment and electronic prior authorizations — key ecosystem enabler rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Accredo Health social profiles

Digital presence

Accredo Health compliance and trust

Trust signal

Compliance5 records

Accredo Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Accredo Health leadership team

Management profile

Number of profiles

Profiles1 record

Accredo Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Accredo Health M&A and investment

M&A and investment

M&A6 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Accredo Health

What does Accredo Health do?

Accredo Health operates as a specialty pharmacy that dispenses specialty medications and provides condition-specific clinical support to patients with complex and chronic conditions, including cancer, hepatitis C, HIV, bleeding disorders, multiple sclerosis, immune disorders, and rare diseases. Services are delivered through 15 Therapeutic Resource Centers staffed by 500+ specialty-trained pharmacists and 600+ infusion nurses, supported by digital tools (mobile app, MyAccredoPatients portal) and AI-enabled prior authorization (Smart Coverage Review, Pharmacy Forward AI).

Is Accredo Health a public or private company?

Accredo Health is a private company. It is classified as corporate owned and is currently operating.

When was Accredo Health founded?

Accredo Health was founded in 2011. It employs 1,001 to 5,000 people.

Where is Accredo Health based?

Accredo Health is headquartered in Memphis, United States, in the North America region.

How does Accredo Health make money?

Four revenue lines are on record. Pharmacy Dispensing Services are the primary driver. The others are clinical and Patient Support Services, AI-Enabled Process Automation and specialty Distribution.

Who are Accredo Health's main competitors?

Direct peers on record are BioMatrix Specialty Pharmacy, CVS Specialty (CVS Health), Optum Specialty Pharmacy (OptumRx), PANTHERx Specialty Pharmacy, Walgreens Specialty Pharmacy and Humana Specialty Pharmacy. Broad incumbents are Express Scripts (Pharmacy Benefit Services) and Cigna / Evernorth Health Services. Diplomat Pharmacy (now part of Optum) is listed as an emerging player. Surescripts is listed as an others.

Does Accredo Health have an API?

No public API is recorded for Accredo Health.

What industry is Accredo Health in?

Accredo Health's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HLAFALAB, Hospital & Health-System Pharmacies (Inpatient/Outpatient). Its NAICS code is 45611 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Straits TimesTrump asks DOJ to probe hospitals over trans health codingThe Trump administration referred over 200 hospitals and clinics, including Boston Children’s Hospital and Cigna’s Accredo Health Group, to the Justice Department and HHS Inspector General for potential violations regarding pediatric gender-affirming care billing. The referral follows a new HHS rule restricting Medicaid funding for such treatments and cites anomalous billing patterns where providers may have used codes for other conditions to cover gender-dysphoria treatments. Vice President JD Vance requested an investigation into whether these coding practices constitute fraud under federal laws.AccredoUnderstanding Limited and Exclusive Distribution NetworksThe article explains the strategic advantages of limited and exclusive distribution networks for pharmaceutical manufacturers, highlighting benefits such as improved patient outcomes, enhanced data collection, and better cost management. It positions Accredo by Evernorth as a key partner capable of managing these specialized networks to ensure therapy integrity and consistent patient care.AccredoThe Right Specialty Pharmacy for Rare & Gene Therapy AccessThe article is a promotional white paper discussing the strategic role of specialty pharmacies in facilitating patient access to rare and gene therapies. It highlights Accredo by Evernorth as a key partner capable of providing clinical excellence, customized access strategies, and advanced distribution capabilities for manufacturers.PR NewswireEvernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in JuneEvernorth Health Services announced that a Humira biosimilar will be available at $0 out of pocket for Accredo patients starting in June, with prices estimated to be 85% lower than the list price for Humira. The initiative, facilitated through Quallent Pharmaceuticals and copay assistance programs, is projected to save individual patients an average of $3,500 annually.EvernorthSpecialty Pharmacy Support for Copay Assistance UsersThe article outlines how specialty pharmacies, specifically citing Accredo, can support patients by managing the complexities of copay assistance programs for high-cost medications. It highlights operational challenges such as navigating manufacturer restrictions and billing variability, which can lead to patient confusion and medication non-adherence if not properly managed. The text emphasizes that proactive enrollment, automated billing, and clear communication are critical for ensuring seamless access to financial aid.PR NewswireMohr Capital Acquires Accredo Health Building In Orlando, FloridaMohr Capital, a Dallas-based real estate investment firm, has acquired a two-story, 78,449-square-foot office building at 6272 Lee Vista Blvd. in Orlando, Florida. The property is fully leased to Accredo Health Group Inc., an Express Scripts company and subsidiary of Cigna Corporation, and marks Mohr Capital's first transaction in Florida and its second acquisition in under 30 days. In 2020, the firm completed 12 transactions across Arizona, California, Florida, Georgia, Indiana and Texas valued at $200 million.PR NewswireCigna Health Services Business Pioneers an Innovative Solution to Affordably Bring Life-Changing Therapies to PatientsCigna's health services business has introduced Embarc Benefit Protection, a new program that eliminates out-of-pocket costs for patients receiving FDA-approved gene therapies like Luxturna and Zolgensma, leveraging expertise from Express Scripts, eviCore, Accredo, and CuraScript SD. The solution is designed to protect employers, health plans, and unions from the high cost shocks associated with breakthrough gene therapies, which are projected to reach over $16 billion in the United States by 2024. Cigna's executives stated the program addresses a growing challenge as more gene therapies receive FDA approval and aims to expand patient access to life-changing treatments without financial barriers.PR NewswireTitan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo®Titan Pharmaceuticals announced on May 13, 2019 that it signed a product purchase and supply agreement with Accredo specialty pharmacy, a subsidiary of Express Scripts, to expand access to its Probuphine buprenorphine implant for opioid use disorder. Titan expects most U.S. Probuphine sales to go through the specialty pharmacy distribution model, which it previously used with AllianceRx Walgreens Prime. Financial terms were not disclosed.PR NewswireAccredo, a Full-Service Specialty Pharmacy, Expands Best-in-Class Services with New Pharmacy in HawaiiExpress Scripts announced that its specialty pharmacy subsidiary, Accredo, will open a new location in Honolulu this summer to serve patients with complex chronic conditions. The facility, which includes an onsite infusion center and home delivery services, has been selected as the preferred provider by Hawaii-based health plan AlohaCare for its members across the state.